Genetic Counseling of Hemophilia Carriers

ABSTRACT

Basic analysis of a potential carrier includes calculation of the probability, or odds, for carriership based on pedigree and clotting factor analysis. Genotype assessment constitutes a more accurate method of carrier detection. Where circumstances permit, the genetic diagnosis of hemophilia should be based on the direct identification of the pathogenic mutation in the factor (F) VIII gene. Neutral mutations in the FVIII gene and the risk of mosaicism (a mixture of normal and mutation carrying cells) in sporadic families may cause misclassification. If it is not possible to use the mutation for diagnostic purposes, it may be possible to use linked polymorphic markers (restriction fragment length polymorphisms [RFLP]) to trace the inheritance of the hemophilia gene within a pedigree. Linkage analysis is limited because of uninformative patterns of polymorphic markers, ethnic variation, linkage disequilibrium, and the need for participation of family members, and it is not useful in sporadic families, which constitute more than half of the hemophilia families. Potential carriers of hemophilia should be offered qualified assistance in genetic information, testing, and counseling to help them to cope with the psychological and ethical problems related to carriership of a genetic disorder.

Hemophilia A - Factor VIII - mutation

REFERENCES

• 1 Peake I R, Lillicrap D P, Boulyjenkov V. et al . Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis [published erratum appears in Blood Coagul Fibrinolysis 1994;5:148].  Blood Coagul Fibrinolysis . 1993;  4 313-344
• 2 Peake I R, Lillicrap D P, Boulyjenkov V. et al . Haemophilia: strategies for carrier detection and prenatal diagnosis.  Bull World Health Organ . 1993;  71 429-458
• 3 Ljung R, Petrini P, Tengborn L, Sjörin E. Haemophilia B mutations in Sweden: a population based study of mutational heterogeneity.  Br J Haematol . 2001;  113 81-86
• 4 Kling S, Ljung R, Sjörin E. et al . Origin of mutation in sporadic cases of haemophilia-B.  Eur J Haematol . 1992;  48 142-145
• 5 Graham J B, Rizza C R, Chediak J. et al . Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype.  Blood . 1986;  67 1554-1559
• 6 Green P P, Mannucci P M, Briet E. et al . Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminant.  Blood . 1986;  67 1560-1567
• 7 Lakich D, Kazazian Jr H H, Antonarakis S E, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A [see comments].  Nat Genet . 1993;  5 236-241
• 8 Naylor J, Brinke A, Hassock S, Green P M, Giannelli F. Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions.  Hum Mol Genet . 1993;  2 1773-1778
• 9 Kemball Cook G, Tuddenham E GD, Wacey A I. The factor VIII structure and mutation resource site: HAMSTeRS version 4.  Nucleic Acids Res . 1998;  26 216-219
• 10 Leuer M, Oldenburg J, Lavergne J M. et al . Somatic mosaicism in haemophilia A: a fairly common event.  Am J Hum Genet . 2001;  69 75-87
• 11 Ljung R, Kling S, Sjörin E, Nilsson I M. More than half the sporadic cases of hemophilia A in Sweden are due to a recent mutation.  Acta Paediatr Scand . 1991;  80 343-348
• 12 Ljung R, Sjörin E. Origin of sporadic cases of haemophilia A.  Br J Haematol . 1999;  106 870-874
• 13 Becker J, Schwaab R, Moller Taube A. et al . Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies.  Am J Hum Genet . 1996;  58 657-670
• 14 Varekamp I, Suurmeijer T P, Brocker Vriends H A. et al . Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers.  Am J Med Genet . 1990;  37 147-154
• 15 Varekamp I, Suurmeijer T, Brocker Vriends A, Rosendaal F R. Hemophilia and the use of genetic counseling and carrier testing within family networks.  Birth Defects Orig Artic Ser . 1992;  28 139-148
• 16 Varekamp I, Suurmeijer T P, Rosendaal F R, Brocker Vriends H A. The use of preventive health care services: carrier testing for the genetic disorder haemophilia.  Soc Sci Med . 1993;  37 639-648
• 17 Tedgård U. Carrier testing and prenatal diagnosis of haemophilia-utilisation and psychological consequences.  Haemophilia . 1998;  4 365-369
• 18 Tedgård U, Ljung R, McNeil T F. How do carriers of hemophilia and their spouses experience prenatal diagnosis by chorionic villus sampling?.  Clin Genet . 1999;  55 26-33
• 19 Tedgård U, Ljung R, McNeil T F. Long-term psychological effects of carrier testing and prenatal diagnosis of haemophilia: comparison with a control group.  Prenat Diagn . 1999;  19 411-417
• 20 Francis Jr B R, Kasper C K. Reproduction in hemophilia.  JAMA . 1983;  250 3192-3195
• 21 Lubs M L. Does genetic counseling influence risk attitudes and decision making?.  Birth Defects Orig Artic Ser . 1979;  15 355-367
• 22 Kraus E M, Brettler D B. Assessment of reproductive risks and intentions by mothers of children with hemophilia.  Am J Med Genet . 1988;  31 259-267
• 23 Hoyer L W, Carta C A, Golbus M S, Hobbins J C, Mahoney M J. Prenatal diagnosis of classic hemophilia (hemophilia A) by immunoradiometric assays.  Blood . 1985;  65 1312-1317
• 24 Tedgård U, Ljung R, McNeil T, Tedgård E, Schwartz M. How do carriers of hemophilia experience prenatal diagnosis (PND)?.  <~>Carriers' immediate and later reactions to amniocentesis and fetal blood sampling. Acta Paediatr Scand . 1989;  78 692-700
• 25 Tedgård U, Ljung R, McNeil T F. Reproductive choices of haemophilia carriers.  Br J Haematol . 1999;  106 421-426
• 26 Beeson D, Golbus M. Decision making: whether or not to have prenatal diagnosis and abortion for X-linked conditions.  Am J Med Genet . 1985;  20 107-114